perugu_vada Posted September 30, 2020 Report Posted September 30, 2020 The greatest improvements were seen in patients who hadn't already mounted a natural response to the infection, the company said. The results only involve 275 patients of the 1,000 they have enrolled in this particular trial, but appear "very promising," Dr. Jeanne Marrazzo, the director of the division of infectious diseases at University of Alabama at Birmingham, told CNN. Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.